Trial Design

Addressing patient dropout with an arsenal of tools that leverages both technology and communication.

Community-based recruitment engages multiple stakeholders in a collaborative approach.

PRO measures enrich the evaluation of treatment effectiveness and help sponsors differentiate products.

Changing demographics and evolving standards of care bring additional challenges when creating protocol designs.

A useful tool for clinical research professionals to estimate potential recruitment duration.

Only eight percent of CNS drugs will reach approval, in part because of the high adverse effects standards.

How partnering can speed companion diagnostic development.

Sponsor-driven, CRO/recruitment provider collaborations propel cost-efficient study completion.

Partnership agreements for CROs and eClinical technology providers can be as beneficial as sponsor/CRO partnerships.

Current commercial forces are working to accelerate the adoption of adaptive monitoring designs.

Survey results show that the recruitment of Latino subjects requires specialized tactics.

Stay in the know with this list of up-to-date, commonly spoken, shortened words that are used often among clinical researchers.

A listing of organizations, colleges, and universities that offer courses specific to advancing the education of clinical research professionals.

Find out the latest on industry organizations and what they offer as membership benefits.

The latest version of the glossary, providing hundreds of definitions for key terminology related to clinical research.

The intent of consent is that participants are comfortable with their choice and can comply with it.

As the popularity of personalized medicine grows the role of the CRO continues to evolve.

The implications and challenges of the placebo effect on regulatory agency product approval.

How will the end of one-size-fits-all medicine effect the clinical trial industry?

Use of complementary and alternative medicine among adult cancer patients.

Two industry insiders offer scientific and operational insight into oncology clinical trials.

Information network allows constituencies to share data and knowledge.